Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 6, 2023; 11(28): 6725-6732
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6725
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6725
Group | Symptom score | Physical sign score | ||||
Nasal itching score | Sneeze score | Runny nose score | Nasal congestion score | |||
Control group | Before therapy | 2.14 ± 0.18 | 2.08 ± 0.32 | 1.84 ± 0.30 | 1.79 ± 0.22 | 2.13 ± 0.27 |
After treatment | 1.76 ± 0.63a | 1.45 ± 0.26a | 1.36 ± 0.06a | 1.37 ± 0.31a | 1.44 ± 0.23a | |
Observation group | Before therapy | 2.04 ± 0.61 | 2.03 ± 0.10 | 1.88 ± 0.80 | 1.82 ± 0.39 | 2.25 ± 0.44 |
After treatment | 1.32 ± 0.31a,b | 1.09 ± 0.26a,b | 0.92 ± 0.24a,b | 1.21 ± 0.31a,b | 1.17 ± 0.37a,b |
- Citation: Qiu C, Feng D. Efficacy and anti-inflammatory analysis of glucocorticoid, antihistamine and leukotriene receptor antagonist in the treatment of allergic rhinitis. World J Clin Cases 2023; 11(28): 6725-6732
- URL: https://www.wjgnet.com/2307-8960/full/v11/i28/6725.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i28.6725